The o2h Ventures ‘Human Health’ funds make tax-efficient EIS and SEIS investments in Pre-Seed and Seed stage companies that address human health. We fund the development of novel therapeutic treatments; we help build new services and tools offerings throughout the biotech ecosystem, and we spur the creation of software & artificial intelligence that will change healthcare.
The o2h team are leaders in the biotech community and have been actively involved as investors, holding various board/industry positions as well as being engaged in grassroots scientific activity for over 20 years. o2h Ventures operates from their proprietary 2.7 acre Mill SciTech Park where they are developing a unique model for incubating small life science companies.
For more information or to invest in the fund, please visit www.o2hventures.com
The o2h team are leaders in the biotech community and have been actively involved as investors, holding various board/industry positions as well as being engaged in grassroots scientific activity for over 20 years. o2h Ventures operates from their proprietary 2.7 acre Mill SciTech Park where they are developing a unique model for incubating small life science companies.
For more information or to invest in the fund, please visit www.o2hventures.com
Location: United Kingdom, England, Cambridge
Employees: 11-50
Founded date: 2018
Investment Stage: Pre-Seed; Seed; Series A
Portfolio 44
| Date | Name | Website | Total Raised | Location |
| 15.09.2024 | Ascend Bio... | ascendbiotx.com | - | - |
| 15.09.2024 | Stratosvir | stratosvir.com | - | - |
| 15.09.2024 | Vesynta | vesynta.com | - | United Kin... |
| 04.04.2024 | CamGene Th... | camgenetx.com | - | - |
| 10.01.2024 | neuroute | neuroute.co | - | United Kin... |
| 26.11.2023 | ViaNautis | vianautis.com | $25M | - |
| - | Oxford Dru... | oxforddrugdesign.com | $14.83M | United Kin... |
| - | PhoreMost | phoremost.com | $116.93M | - |
| - | Metrion Bi... | metrionbiosciences.com | $9.3M | United Kin... |
| - | Tay Therap... | in4derm.co.uk | - | United Kin... |
Show more
Persons 13
| Date | First Name | Last Name | Title | Location | |||
| - | Andy | Morley | Principal | linkedin.c... | - | - | - |
| - | Shubham | Tiwari | Deal Flow ... | linkedin.c... | - | - | - |
| - | Dr | Nigel Pitc... | Venture Pa... | linkedin.c... | - | - | - |
| - | Ajit | Singh Gull... | Marketing ... | linkedin.c... | - | - | - |
| - | Jeff | Roix | Venture Pa... | linkedin.c... | - | - | - |
| - | David | Barrett | Senior Ven... | linkedin.c... | - | - | - |
| - | R | G Boyle | Independen... | linkedin.c... | - | - | - |
| - | W. | Graham Ric... | Independen... | linkedin.c... | - | - | - |
| - | Catherine | Beech | Independen... | - | - | - | |
| - | Cengiz | Tarhan | Independen... | linkedin.c... | - | - | - |
Show more
Mentions in press and media 4
| Date | Title | Description |
| 13.11.2020 | o2h ventures launches the first HMRC approved knowledge intensive EIS fund focused on UK biotech therapeutics & AI | o2h ventures has announced the launch of its HMRC approved knowledge intensive EIS fund, focusing on supporting the expansion of UK research and development in biotech therapeutics and AI. To support the Government’s aim to strengthen and g... |
| 13.11.2020 | o2h ventures launches the first HMRC approved knowledge intensive EIS fund focused on UK biotech therapeutics & AI | o2h ventures launches the first HMRC approved knowledge intensive EIS fund focused on UK biotech therapeutics & AI 13-11-2020 o2h ventures has announced the launch of its HMRC approved knowledge intensive EIS fund, focusing on supportin... |
| 08.06.2020 | Qkine secures £1.5M Series A funding from leading life science investors | Qkine today announced the successful closure of a £1.5M Series A investment round to accelerate the global scale-up of its commercial operations and make key hires to its leadership team. Qkine – a specialist developer and manufacturer of p... |
| 08.06.2020 | Qkine secures £1.5M Series A funding from leading life science investors | Qkine secures £1.5M Series A funding from leading life science investors 08-06-2020 Qkine today announced the successful closure of a £1.5M Series A investment round to accelerate the global scale-up of its commercial operations and make ke... |